HCA Healthcare, Inc. $HCA Shares Bought by Ally Financial Inc.

Key Points

• Ally Financial Inc. increased its position in HCA Healthcare, raising its holdings by 50% to a total of 4,500 shares, which are valued at approximately $1,555,000.
• HCA Healthcare reported earnings of $6.84 per share for the last quarter, exceeding analysts' estimates, with a year-over-year revenue increase of 6.4%.
• The company announced a quarterly dividend of $0.72 per share, which will be paid on September 30, reflecting an annual yield of 0.7%.

Ally Financial Inc. boosted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 50.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 4,500 shares of the company's stock after purchasing an additional 1,500 shares during the quarter. Ally Financial Inc.'s holdings in HCA Healthcare were worth $1,555,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. Avantax Advisory Services Inc. raised its holdings in shares of HCA Healthcare by 0.4% during the first quarter. Avantax Advisory Services Inc. now owns 8,077 shares of the company's stock valued at $2,791,000 after acquiring an additional 32 shares during the last quarter. Horizon Investments LLC increased its holdings in shares of HCA Healthcare by 1.1% in the first quarter. Horizon Investments LLC now owns 3,175 shares of the company's stock valued at $1,097,000 after purchasing an additional 33 shares during the last quarter. Catalyst Financial Partners LLC increased its holdings in shares of HCA Healthcare by 4.3% in the first quarter. Catalyst Financial Partners LLC now owns 872 shares of the company's stock valued at $301,000 after purchasing an additional 36 shares during the last quarter. RWA Wealth Partners LLC increased its holdings in shares of HCA Healthcare by 2.0% in the first quarter. RWA Wealth Partners LLC now owns 1,904 shares of the company's stock valued at $658,000 after purchasing an additional 37 shares during the last quarter. Finally, Moors & Cabot Inc. increased its holdings in shares of HCA Healthcare by 4.8% in the first quarter. Moors & Cabot Inc. now owns 858 shares of the company's stock valued at $297,000 after purchasing an additional 39 shares during the last quarter. Institutional investors own 62.73% of the company's stock.

HCA Healthcare Stock Down 0.3%

NYSE:HCA traded down $1.05 during midday trading on Tuesday, reaching $401.72. The company had a trading volume of 1,180,566 shares, compared to its average volume of 1,273,427. The firm has a market capitalization of $94.00 billion, a price-to-earnings ratio of 16.89, a PEG ratio of 1.27 and a beta of 1.39. The stock's fifty day simple moving average is $375.19 and its 200-day simple moving average is $355.12. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $417.14. The company has a current ratio of 0.98, a quick ratio of 0.86 and a debt-to-equity ratio of 69.07.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its earnings results on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The firm had revenue of $18.61 billion during the quarter, compared to analyst estimates of $18.49 billion. During the same period last year, the business posted $5.50 earnings per share. HCA Healthcare's revenue was up 6.4% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, sell-side analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th will be paid a $0.72 dividend. The ex-dividend date is Tuesday, September 16th. This represents a $2.88 dividend on an annualized basis and a yield of 0.7%. HCA Healthcare's dividend payout ratio (DPR) is currently 12.11%.

Analyst Ratings Changes

Several equities research analysts recently commented on the company. Truist Financial increased their price target on HCA Healthcare from $390.00 to $415.00 and gave the company a "buy" rating in a report on Wednesday, July 16th. Wall Street Zen upgraded HCA Healthcare from a "hold" rating to a "buy" rating in a research report on Saturday, July 5th. Wolfe Research lowered HCA Healthcare from an "outperform" rating to a "peer perform" rating in a research report on Monday, July 28th. Cantor Fitzgerald reiterated an "overweight" rating and issued a $444.00 price objective on shares of HCA Healthcare in a research report on Tuesday. Finally, JPMorgan Chase & Co. increased their price objective on HCA Healthcare from $360.00 to $370.00 and gave the stock a "neutral" rating in a research report on Monday, August 4th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and nine have given a Hold rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $401.83.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.